Alvogen Company Profile

What is the competitive landscape for ALVOGEN

ALVOGEN has fifty-three approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Summary for Alvogen

US Patents:	0
Tradenames:	43
Ingredients:	41
NDAs:	53
Patent Litigation for Alvogen:	See patent lawsuits for Alvogen
PTAB Cases with Alvogen as petitioner:	See PTAB cases with Alvogen as petitioner

Drugs and US Patents for Alvogen

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	207388-004	Jul 28, 2017	AB	RX	No	No
Alvogen	LIDEX	fluocinonide	SOLUTION;TOPICAL	018849-001	Apr 6, 1984		DISCN	Yes	No
Alvogen	NATEGLINIDE	nateglinide	TABLET;ORAL	205055-002	Dec 11, 2015		DISCN	No	No
Alvogen	LENALIDOMIDE	lenalidomide	CAPSULE;ORAL	210480-005	Mar 6, 2023	AB	RX	No	No
Alvogen	BUTALBITAL AND ACETAMINOPHEN	acetaminophen; butalbital	TABLET;ORAL	205120-001	Oct 30, 2015		DISCN	No	No

Expired US Patents for Alvogen

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-001	May 24, 1985	4,066,755
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-003	Jun 3, 1988	3,900,481
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982	3,592,930
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-004	Aug 1, 1984	4,066,755
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-003	Aug 1, 1984	4,012,444

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Alvogen
• Alvogen Pine Brook